Patients Stopping Weight-Loss Medications Put On Pounds at a Quadrupled Rate Compared to Dieters

A recent study suggests that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle regimens.

Research printed in a leading medical journal demonstrates that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"Users using such drugs need to be aware of the potential of quick weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.

Such speed of recovery implies a return to starting mass within about 18 months.

Comparing Approaches

The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with older methods.

Scientists note that individuals who lose weight through lifestyle changes alone generally see a slower creep back—around 100 grams monthly—once they finish.

Understanding the Rapid Rebound

Nutrition scientists suggest the way of the jabs explains the heightened rebound.

GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate hunger.

"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making overeating far more likely."

A Lifelong Issue?

The NHS advise the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals argue that, due to the significant potential of weight regain, the treatment might need to be life-long.

This perspective is echoed by drug manufacturers, who say that the results "highlight the persistent character of excess weight," akin to managing diseases like hypertension.

Patient Testimonies

Users who have come off the medication describe a powerful return of cravings.

"It felt as if a trigger that goes on and I was suddenly ravenous," described one woman.

This challenge is compounded if users have not adopted sustainable lifestyle or habit changes during treatment.

Growing Interest

Recent estimates indicate that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is more common among women than males.
• The 40s and 50s age group shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, experts emphasize that while the jabs are powerful agents for weight loss, they are not a permanent fix and maintained weight loss relies on combined behavioural changes.